Health

Results: 1225-1236 of 8121

Curia Invests $4 Million to Enhance Sterile API Manufacturing

Sai Life Sciences set to double Process R&D capacity with new facility in Hyderabad

Sai Life Sciences Set to Double Process R&D Capacity With New Facility in Hyderabad

Stigma, Not Condition, Is the Biggest Barrier for 1 in 3 People Living With Chronic Conditions, According to New Convatec Research

KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in Saudi Arabia

NHS-licensed healthcare platform Evaro partners with period tracking app Clue in UK-first integration

Implantica presents the third quarter 2025 on October 31 at 15:00 CET

Inside information: Bioretec is revising its financial targets, deems that the current financial targets will not be met and withdraws its financial targets

Stockholm hospitals unify all imaging in Sectra's cloud service to boost collaboration and patient care

Professor Nguyen Thanh Liem, Director, Institute of Stem Cell and Genetic Technology Research at Vinmec International Hospital, Hanoi, Vietnam and his team have successfully implemented the technology transfer of Autologous Immune Enhancement Therapy (AIET) from Japan and demonstrated its safety and efficacy as an adjuvant in combination with standard of care in various cancers. Prof. Liem, a renowned pediatric surgeon and pioneer in regenerative medicine, has received numerous prestigious honors, including the 2018 Nikkei Asia Prize for Science & Technology, the Ho Chi Minh Prize, the Hero of Labor Medal, and the Vietnamese Talent Award. In 2025, he was named among the world's most influential scientists by a Stanford University, USA research group. Driven by a passion to improve cancer patients’ quality of life, Prof. Liem successfully brought AIET to Vietnam in 2018 transferred by GN Corporation, Japan, technically supported by Nichi-In Centre for Regenerative Medicine (NCRM)

Colorectal, Liver, and Lung Cancer Patients at Vinmec Experience Extended Survival with AIET Cell-Based Immunotherapy – Technology Transferred from Japan

World's First Multi-Omics LLM, Promising to Decode the Language of Human Biology Showcasing in Global Health Exhibition, Riyadh

PR Newswire associated0

CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE)

Health Canada Grants Authorization for Leqembi® (lecanemab)